Today's health news spans drug trial failures and advances, nutritional health discoveries, and breakthroughs in diagnostic imaging and genetic disease treatments.

Vistagen Therapeutics' experimental anxiety disorder drug failed to meet primary endpoints in late-stage trials, causing significant stock decline and highlighting challenges in psychiatric drug development.

The FDA's staff reviewers raised serious safety concerns about peptides manufactured by compounding pharmacies, stating insufficient evidence supports their benefits for seven popular preparations.

Africa CDC urgently seeks $18 million in funding to accelerate trials of experimental Ebola treatments in the Democratic Republic of Congo amid ongoing outbreak response efforts.

Nutritional deficiencies may underlie personality symptoms including cravings, cognitive issues, and low energy, prompting recommendations for comprehensive nutritional assessments in affected patients.

Exclusive breastfeeding significantly reduces cardiometabolic risk in women with polyendocrine metabolic ovarian syndrome who experienced high-risk pregnancies, according to new research.

Women with rectovaginal endometriosis achieve comparable pain relief and quality-of-life improvements through either surgical intervention or hormonal therapy, supporting personalized treatment approaches.

Ultrafast ultrasound shear wave elastography presents a non-invasive breakthrough method for detecting heart muscle stiffening in patients with congenital aortic stenosis.

Generic formulations of elexacaftor-tezacaftor-ivacaftor demonstrate real-world safety and efficacy in children and adolescents with cystic fibrosis, potentially improving medication access and affordability.